Review
World J Pharmacol
3(4):39-55.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.39
Abstract (1568)
|
Core Tip (1282)
|
Full Article (HTML) (13332)
|
Figures (1-3) (208)
|
Tables (1-5) (230)
|
Full Article (PDF)-1451K (1157)
|
Peer-Review Report-94K (336)
|
Answering Reviewers-72K (261)
|
Received: 06/26/2014
|
Revised: 09/09/2014
|
Accepted: 10/10/2014
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (55)
|
Total Visits (24302)
|
Similar Articles (6)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):56-71.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.56
Abstract (1559)
|
Core Tip (1251)
|
Full Article (HTML) (8112)
|
Figures (1-1) (337)
|
Tables (1-3) (183)
|
Full Article (PDF)-1210K (651)
|
Peer-Review Report-98K (286)
|
Answering Reviewers-99K (236)
|
Received: 07/01/2014
|
Revised: 08/01/2014
|
Accepted: 09/17/2014
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (15800)
|
Similar Articles (151)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):72-85.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.72
Abstract (1418)
|
Core Tip (1250)
|
Full Article (HTML) (8907)
|
Figures (1-4) (586)
|
Tables (1-1) (176)
|
Full Article (PDF)-1374K (988)
|
Peer-Review Report-105K (269)
|
Answering Reviewers-58K (335)
|
Received: 07/28/2014
|
Revised: 08/29/2014
|
Accepted: 09/24/2014
|
CrossRef
|
Google Scholar
|
Times Cited (8)
|
Total Visits (17283)
|
Similar Articles (6)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):86-96.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.86
Abstract (1276)
|
Core Tip (1219)
|
Full Article (HTML) (6302)
|
Figures (1-3) (270)
|
Full Article (PDF)-2317K (719)
|
Peer-Review Report-102K (271)
|
Answering Reviewers-250K (334)
|
Received: 07/28/2014
|
Revised: 10/01/2014
|
Accepted: 10/29/2014
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (13282)
|
Similar Articles (2)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):97-109.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.97
Abstract (1055)
|
Core Tip (933)
|
Full Article (HTML) (4332)
|
Figures (1-1) (174)
|
Tables (1-4) (179)
|
Full Article (PDF)-1455K (622)
|
Peer-Review Report-129K (158)
|
Answering Reviewers-81K (181)
|
Received: 06/28/2014
|
Revised: 10/02/2014
|
Accepted: 11/10/2014
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (10277)
|
Similar Articles (0)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Harnessing pharmacological knowledge for personalized medicine and pharmacotyping: Challenges and lessons learned
![](https://www.f6publishing.com/contents/images/coretip.png)
World J Pharmacol
3(4):110-119.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.110
Abstract (1168)
|
Core Tip (919)
|
Full Article (HTML) (3412)
|
Figures (1-1) (215)
|
Tables (1-1) (189)
|
Full Article (PDF)-2534K (462)
|
Peer-Review Report-98K (226)
|
Answering Reviewers-19K (156)
|
Received: 06/12/2014
|
Revised: 07/03/2014
|
Accepted: 10/29/2014
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (10153)
|
Similar Articles (4)
|
Timeline of Article Publication (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):120-139.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.120
Abstract (1435)
|
Core Tip (1089)
|
Full Article (HTML) (7502)
|
Figures (1-2) (255)
|
Tables (1-1) (147)
|
Full Article (PDF)-1376K (634)
|
Peer-Review Report-116K (316)
|
Answering Reviewers-78K (302)
|
Received: 06/29/2014
|
Revised: 09/01/2014
|
Accepted: 09/24/2014
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (17210)
|
Similar Articles (62)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):140-152.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.140
Abstract (1387)
|
Core Tip (1227)
|
Full Article (HTML) (6652)
|
Figures (1-2) (136)
|
Tables (1-1) (137)
|
Full Article (PDF)-2415K (436)
|
Peer-Review Report-106K (343)
|
Answering Reviewers-72K (217)
|
Received: 06/27/2014
|
Revised: 10/02/2014
|
Accepted: 11/03/2014
|
CrossRef
|
Google Scholar
|
Times Cited (13)
|
Total Visits (13260)
|
Similar Articles (0)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(1)
|
Open
Minireviews
Pharmacological role of efflux transporters: Clinical implications for medication use during breastfeeding
![](https://www.f6publishing.com/contents/images/coretip.png)
World J Pharmacol
3(4):153-161.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.153
Abstract (1253)
|
Core Tip (1147)
|
Full Article (HTML) (4895)
|
Figures (1-1) (167)
|
Full Article (PDF)-1040K (518)
|
Peer-Review Report-104K (264)
|
Answering Reviewers-60K (204)
|
Received: 06/28/2014
|
Revised: 09/03/2014
|
Accepted: 09/24/2014
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (11513)
|
Similar Articles (9)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):162-173.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.162
Abstract (1314)
|
Core Tip (1320)
|
Full Article (HTML) (5888)
|
Figures (1-2) (207)
|
Tables (1-1) (140)
|
Full Article (PDF)-4747K (707)
|
Peer-Review Report-116K (305)
|
Answering Reviewers-128K (288)
|
Received: 06/27/2014
|
Revised: 08/07/2014
|
Accepted: 10/29/2014
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (15556)
|
Similar Articles (2)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):174-185.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.174
Abstract (1043)
|
Core Tip (851)
|
Full Article (HTML) (3723)
|
Tables (1-1) (174)
|
Full Article (PDF)-1054K (342)
|
Peer-Review Report-106K (238)
|
Answering Reviewers-75K (165)
|
Received: 07/29/2014
|
Revised: 10/02/2014
|
Accepted: 10/27/2014
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (9225)
|
Similar Articles (17)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):186-192.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.186
Abstract (1236)
|
Core Tip (959)
|
Full Article (HTML) (5929)
|
Tables (1-2) (165)
|
Full Article (PDF)-872K (579)
|
Peer-Review Report-82K (271)
|
Answering Reviewers-100K (234)
|
Received: 05/16/2014
|
Revised: 07/04/2014
|
Accepted: 09/17/2014
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (13352)
|
Similar Articles (28)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Therapeutics Advances
World J Pharmacol
3(4):193-198.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.193
Abstract (1064)
|
Core Tip (831)
|
Full Article (HTML) (2055)
|
Figures (1-2) (124)
|
Tables (1-1) (140)
|
Full Article (PDF)-1053K (292)
|
Peer-Review Report-98K (263)
|
Answering Reviewers-31K (158)
|
Received: 06/24/2014
|
Revised: 09/22/2014
|
Accepted: 10/10/2014
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (10148)
|
Similar Articles (720)
|
Timeline of Article Publication (2)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Evidence-Based Medicine
World J Pharmacol
3(4):199-208.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.199
Abstract (1216)
|
Core Tip (1070)
|
Full Article (HTML) (6132)
|
Tables (1-4) (209)
|
Full Article (PDF)-1067K (536)
|
Peer-Review Report-118K (259)
|
Answering Reviewers-113K (271)
|
Received: 07/28/2014
|
Revised: 09/08/2014
|
Accepted: 10/16/2014
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (13060)
|
Similar Articles (72)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Systematic Reviews
Association of serum bilirubin and non-alcoholic fatty liver disease: A feasible therapeutic avenue?
![](https://www.f6publishing.com/contents/images/coretip.png)
World J Pharmacol
3(4):209-216.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.209
Abstract (1222)
|
Core Tip (971)
|
Full Article (HTML) (8122)
|
Figures (1-1) (166)
|
Tables (1-2) (185)
|
Full Article (PDF)-1014K (402)
|
Peer-Review Report-80K (243)
|
Answering Reviewers-67K (195)
|
Received: 05/21/2014
|
Revised: 07/14/2014
|
Accepted: 10/27/2014
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (14959)
|
Similar Articles (205)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open